Bridging the gap between ortho and restorative treatment

The practitioner who wishes to get started in GDP orthodontics faces a bewildering array of choices: clear aligners or fixed appliances? Which product is best to get started with? How to overcome one’s poor foundation of orthodontic knowledge from undergraduate training, when much of the information learned for final exams has subsequently been forgotten? Since 2001, the Invisalign product has been used to treat over 5 million cases worldwide. This vast bank of clinical experience is constantly used to refine and improve the product, and also makes the Invisalign system the most streamlined experience for a new user who is improving their orthodontic skills and the safest place to re-start one’s journey in orthodontics.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

PHARMACEUTICAL FORENSICS FOR SAFE MANUFACTURING AND SUPPLY

Biopharma-asia

Pharmaceutical Investigations and Technology (PIT) is a group within Global Analytical Technology (GAT) department in the commercial Quality organization within Bristol-Myers Squibb. The PIT group has been a key part in BMS for 30 + years in providing analytical support for commercial manufacturing and in pharmaceutical forensics. This include particulate and foreign matter characterization in pharmaceutical products and screening counterfeit drugs. Several analytical tools and techniques are used by PIT to support the pharmaceutical forensics.
Watch Now

Building data and intelligence capabilities to provide evidence of impact for the profession

Pharmacy needs to build sustained data and analytics capabilities that support evidence-based decision making and advocacy interventions that inform policy development.
Watch Now

Pharmaceutical Spray Drying to Overcome Poor Drug Solubility

quotientsciences

This webinar will focus on the benefits of spray-drying in addressing the solubility challenge, detailing how simple, scaleable systems can be quickly developed to provide drug products for clinical evaluation. Approaches for transitioning spray-dried dispersions to formulated solid oral dosage forms for downstream development will also be described.
Watch Now

The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan

pharmaphorum

Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK government has already set out two plans for the future shape of the country’s healthcare industry: the second Life Sciences Sector Deal and the long-term plan for the NHS. With these two plans in place there are plenty of opportunities for the industry and the government to work together to keep the UK at the top of the international life sciences sector – and perhaps reach even greater heights.
Watch Now

Spotlight

resources